ExlService Holdings enters its third-quarter report on October 27 with something it has not always enjoyed: the benefit of the doubt. Management has raised its full-year outlook twice in a row, its data and AI-led business has accelerated for four straight quarters, and the stock has climbed 26.5% since the last report while the S&P 500 managed just 3.2%. That combination makes this an expectations test as much as an earnings report. The question is no longer whether EXL's AI pivot is real, but whether the second half can hold up against a bar the company itself has steadily raised.

Wall Street is looking for non-GAAP earnings of $0.56 a share on revenue of $616.3 million, which would represent growth of about 16.4% from the $529.6 million reported a year ago and a solid step up from last quarter's $594.8 million. The Earnings Whisper sits at $0.58, a modest notch above consensus that suggests the informal bar is slightly higher than the published one, though not dramatically so. Part of the revenue gain will come from iMerit, the acquisition that closed July 31 and that management expects to contribute roughly $28 million to $32 million over the final five months of the year. With two of those months falling in the September quarter, investors should be able to separate the acquired contribution from organic growth, and that split matters a great deal.

Here is why. After lifting full-year revenue guidance to $2.39 billion to $2.415 billion, implying 14% to 16% reported growth, and earnings to $2.25 to $2.29 a share, management still framed the second half as a period of slower organic growth. At least one analyst pushed back on the call, arguing the implied deceleration looked conservative against first-half momentum, and management attributed it to prudence around macro uncertainty and integration. When the raise was issued, the Street's full-year earnings estimate sat at the bottom of the new range and its revenue estimate well below it, leaving clear room for upside. A quarter that shows organic growth holding closer to first-half levels, with data and AI-led revenue still growing near 30%, would validate the view that guidance is cushioned. Evidence that core growth is fading once iMerit is stripped out would undercut it.

Segment breadth is the second test. Insurance reaccelerated to 15% growth, international markets jumped above 16% under new leadership, and healthcare held around 22%. Sustaining that broad reacceleration would show the strength is not concentrated in one vertical. The weak spot, reported digital operations, has been shrinking as work migrates into AI-led offerings, and management has called that intentional. That explanation holds only if total operations growth stays near the 10% pace of recent quarters.

Margins are where a good revenue print could still disappoint. Management explicitly guided second-half adjusted operating margin below the first half, citing heavier front-end sales and AI investment, plus a small drag from India's new labor codes. A step down from last quarter's 19.7% is expected; a sharper decline, or one paired with soft organic growth, would raise questions about how much it costs to fund the pivot. Early signs that iMerit is opening doors with frontier model developers, or that token optimization is winning commercial traction, would help justify that spending.

Sentiment has warmed noticeably, moving from 13.1% bearish ahead of the last report to essentially neutral, and the stock at $39.52 trades about 20% above its 200-day moving average and within 2% of its post-earnings high of $40.29. That positions shares to test a breakout, but also leaves less cushion for a merely in-line quarter. Ultimately, the report hinges on one issue: whether organic growth outside iMerit stays strong enough to make the second-half guide look conservative rather than candid. If it does, a third raise becomes plausible. If not, the stock's recent run may already reflect the good news.